Adjuvant treatment with cancer vaccine + Keytruda shows continued improvement in RFS and DMFS in resected high-risk advanced melanoma

Senate Finance Committee advances RFK Jr. to likely confirmation, with Bill Cassidy (R-LA) casting the deciding vote

Robert F. Kenedy Jr., an antivaccine advocate and President Trump’s MAHA nominee, has cleared a key hurdle to be confirmed as secretary of Health and Human Services.

February 07, 2025

Vol.51 No.05

By Claire Marie Porter

Clinical Roundup

Cancer vaccine shows promise for patients with stage 3 and 4 kidney cancer

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage 3 or 4 clear cell renal cell carcinoma generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

February 07, 2025

Vol.51 No.05

Clinical Roundup

Urine test for prostate cancer could be used at home, study finds

Researchers at Vanderbilt and the University of Michigan have shown that an at-home urine test for prostate cancer screening is highly accurate.

February 07, 2025

Vol.51 No.05

Capitol Hill

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate
The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services.

January 31, 2025

Vol.51 No.04

By Claire Marie Porter

Drugs & Targets

FDA grants RP1 BLA priority review for advanced melanoma

FDA has accepted the Biologics License Application from Replimune Group Inc. for RP1 (vusolimogene oderparepvec) in combination with nivolumab (Opdivo) for patients with advanced melanoma.

January 24, 2025

Vol.51 No.03

Capitol Hill

As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.

November 22, 2024

Vol.50 No.44

By Paul Goldberg

Adjuvant treatment with cancer vaccine + Keytruda shows continued improvement in RFS and DMFS in resected high-risk advanced melanoma

YOU MAY BE INTERESTED IN

Senate Finance Committee advances RFK Jr. to likely confirmation, with Bill Cassidy (R-LA) casting the deciding vote

Cancer vaccine shows promise for patients with stage 3 and 4 kidney cancer

Urine test for prostate cancer could be used at home, study finds

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate
The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

FDA grants RP1 BLA priority review for advanced melanoma

As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

Renew today!

Subscriber content

Never miss an issue!

Login

Adjuvant treatment with cancer vaccine + Keytruda shows continued improvement in RFS and DMFS in resected high-risk advanced melanoma

YOU MAY BE INTERESTED IN

Senate Finance Committee advances RFK Jr. to likely confirmation, with Bill Cassidy (R-LA) casting the deciding vote

Cancer vaccine shows promise for patients with stage 3 and 4 kidney cancer

Urine test for prostate cancer could be used at home, study finds

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the SenateThe MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

FDA grants RP1 BLA priority review for advanced melanoma

As Trump’s second term nears, Republican support for NIH is at a low pointBy stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

Never miss an issue!

Login

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate
The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research